1. How to submit my research paper? What’s the process of publication of my paper?
The journal receives submitted manuscripts via email only. Please submit your research paper in .doc or.pdf format to the submission email: ijlbpr@ejournal.net.
You’ll be given a paper number if your submission is successful. Your paper then will undergo peer review process, which may take approximately one and a half months under normal circumstances, three tops.
After blind peer review, you will receive the notification letter with the review result of your paper...
2. Can I submit an abstract?
The journal publishes full research papers. So only full paper submission should be [Read More]

Editor Guidelines

As an Editor of the Editorial Board, you will be contributing greatly to the prestige of our journal and the high standards of peer review. The role of the Editor in scholarly publishing is the management of the peer review of manuscripts by reviewers. The Editors for the publications of the International Journal of Life Sciences Biotechnology and Pharma Research are responsible for the consistency and reputation of our journals. By assuring the selection of appropriate reviewers to identify quality manuscripts, and by efficiently managing the peer review process, the quality and value of our publications are increased. IJLBPR requires the peer review of all papers that appear in our journals and papers are selected for publication on the basis of novelty, quality and appropriateness.

Assigning Editor

The Editor-in-Chief will assign an Editor to the manuscript based on a submission's subject area, by sending the Editor an email requesting that he/she handles the review process. The author is notified that the manuscript has been sent out for review and is given the name of the assigned Editor. If a submission is sent directly to the Editor, he/she can directly arrange the peer review with or without notifying the Editor-in-Chief until a final Accept/Reject decision has been made.

Review

The Editor first evaluates all manuscripts. It is rare but entirely feasible for an exceptional manuscript to be accepted at this stage. Those rejected at this stage are insufficiently original, have serious scientific flaws, have poor grammar or English language, or are outside the aims and scope of the journal. Should the Editor decide to not assign reviewers but instead reject the submission, he/she is required to provide comments to be returned to the author.

Those that meet the minimum criteria are passed on to preferable 3 but at least 2 experts for review. Suggestions for referees from the author are welcome, though these recommendations may or may not be used. Editors will solicit reviewers with the title and an abstract of the submission and, if accepted, send reviewers the submission via email. Editors should guide referees with Reviewer Guidelines. Referees directly return their reviews to the Editor by email. Unless the Editor makes specific arrangements with a reviewer, the deadline to return a completed review is 3 weeks.

Making Decisions

Referees advise the Editor, who is responsible for making the final decision to accept or reject the article. The Editor will determine the disposition of the manuscript, based on remarks of the reviewers, and the Editor’s own assessment of the manuscript. The Editor must then promptly convey this decision to the author. The author may contact the Editor if instructions regarding amendments to the manuscript are unclear. The Editor should be sure to never disclose the names of reviewers to authors.
Copyright © 2012-2015 International Journal of Life Sciences Biotechnology and Pharma Research, All Rights Reserved